M.G. Chambers

The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse

S.S. Glasson, M.G. Chambers, W. B. Van Den Berg et al. · Osteoarthritis and Cartilage · 2010 · 1.7K citations · Full text

Histological Assessments, Rheumatology, Musculoskeletal Research +7

Gene deletion of either interleukin‐1β, interleukin‐1β–converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy

Kristen M. Clements, Joanne S. Price, M.G. Chambers et al. · Arthritis & Rheumatism · 2003 · 211 citations

Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Xingrong Liu, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2012 · 160 citations · Full text

Small Molecule Inhibitors, Broad Kinase Selectivity, Drug Target +19

Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Bryan Chan, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2013 · 121 citations · Full text

Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain

Robert J. Benschop, Emily C. Collins, Ryan J. Darling et al. · Osteoarthritis and Cartilage · 2014 · 119 citations

Inflammation, Gene-related Peptide, Rheumatoid Disorder +11